Forte Biosciences, Inc.
Clinical trials sponsored by Forte Biosciences, Inc., explained in plain language.
-
New hope for vitiligo: experimental drug FB102 enters human trials
Disease control Recruiting nowThis study tests a new medicine called FB102 for people with non-segmental vitiligo, a condition that causes white patches on the skin. The trial will include 64 adults and aims to see if FB102 is safe and can help restore skin color on the face. Participants will receive either …
Phase: PHASE1 • Sponsor: Forte Biosciences, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug trial hopes to regrow hair in severe alopecia
Disease control Recruiting nowThis early-stage study tests a new medicine called FB102 for people with severe to very severe alopecia areata, a condition causing major hair loss. About 32 adults will receive either FB102 or a placebo to see if the drug is safe and helps hair grow back. The main goal is to che…
Phase: PHASE1 • Sponsor: Forte Biosciences, Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New drug aims to shield celiac patients from accidental gluten
Disease control Recruiting nowThis study tests an experimental drug called FB102 in 100 adults with celiac disease who already follow a strict gluten-free diet. Participants will receive either the drug or a placebo and then undergo a controlled gluten challenge to see if the drug can reduce intestinal damage…
Phase: PHASE2 • Sponsor: Forte Biosciences, Inc. • Aim: Disease control
Last updated May 06, 2026 16:15 UTC